Company Filing History:
Years Active: 1981
Title: Howard L Liber: Innovator in Mutagenesis Assays
Introduction
Howard L Liber is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of genetic research, particularly in the area of mutagenesis. His work focuses on developing assays that can detect mutagenic damage in human cells.
Latest Patents
Howard L Liber holds a patent for an "Assay for mutagenesis in heterozygous diploid human lymphoblasts." This innovative assay is designed to determine mutagenic damage caused by the administration of known or suspected mutagens to diploid human lymphoblastoid cell lines. The assay utilizes the gene locus for thymidine kinase, uridine kinase, or cytidine deaminase. By employing heterozygotes of human lymphoblastoid cells, this assay provides a reliable method for assessing mutagenic effects.
Career Highlights
Howard L Liber is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in genetic assays. His work has been instrumental in understanding the implications of mutagenesis in human health.
Collaborations
Throughout his career, Howard has collaborated with esteemed colleagues such as Thomas R Skopek and Bruce W Penman. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Howard L Liber's innovative work in mutagenesis assays highlights his significant role in genetic research. His contributions continue to impact the scientific community and enhance our understanding of mutagenic effects on human cells.